Drugs / H5N1 vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01578317 | Mar 2012 → Jan 2016 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00383071 Comparator | Aug 2006 → Mar 2010 | avian influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H5N1 vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01578317 ↗ |
| Modality | Vaccine | “This study will use an experimental bird flu vaccine to stimulate immune globulin production in healthy people.” NCT00383071 ↗ |
| Route | Intramuscular | “H5N1 vaccine - 90 mcg IM every 4 week x 4 doses” NCT00383071 ↗ |